Devices, diagnostics, wearables
50 stories
In the last 7 days, Medical Devices tracked 2 stories — 50% positive, 50% neutral sentiment, averaging 5.5/10 impact.
Stories appear on this page because our classification stage assigned them this category as their primary topic — each story receives exactly one category per niche, chosen from a fixed list, so a story that touches both a funding round and a product launch in the same week sorts into whichever category best matches its dominant subject, not both. This keeps each category page focused on one beat rather than a blend of unrelated developments, and applies the same source-verification standard used across every story on this site. Sentiment measures the directional read of each development for this category specifically, not the tone of the reporting, and impact weights how consequential a development is — regulatory, financial, or operational — rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Abbott raises its 2026 profit outlook as medical device sales jump 9% to $5.85B and diabetes care climbs 11%, proving the resilience of advanced cardiac and CGM technologies. The beat and guidance hike signal that hospitals continue to prioritize high-acuity procedures even under volume pressure.
A new soft floating robot with zero mechanical pinch points could become a safe companion for patients in healthcare settings, reducing injury risk during human-robot interaction. The demo from Keio University and MIT Media Lab highlights gentle, full-body movements that may help elderly or cognitively impaired users feel at ease without the whirring and rigidity of traditional robots.
Medical device makers Insulet and Embecta face class actions alleging hidden defects and demand weaknesses for insulin delivery products, causing steep investor losses.
Analyst downgrades reflect growing fears that GLP-1 weight loss drugs could erode the sleep apnea device market, even as ResMed’s financials stay solid. The contrast between a $225 low target and $321 high target underscores sector uncertainty.
An affordable, lab-friendly placenta-on-chip from India reproduces hormone secretion, nutrient transfer, waste removal, and barrier function, while modeling gestational diabetes. Its simple design may replace animal models for drug safety screening in pregnancy.
Source: Anshul Bhide (in) · Payal Banerjee (in)
Intuitive Surgical's decision to extend force-feedback tool usage from 6 to 15 uses could accelerate robotic surgery adoption in hospitals, easing supply chain woes and lowering per-procedure costs without sacrificing revenue.
Source: The Motley Fool · James Halley (us)
BellaSeno announced two-year follow-up data from its first-in-human breast scaffold trial, showing an 83% mean volume retention and zero scaffold-related complications in 19 patients. An additional 11 patients are enrolled in a pivotal Australian trial, with global commercialization as the next goal.
Source: Globe Newswire · Globenewswire_fr
The HHS mandate requiring at least 10% of exam tables, chairs, scales, and other MDE to be accessible will reshape provider operations. With the July 8, 2026 deadline imminent, clinics and hospitals must upgrade equipment to serve patients with mobility disabilities and avoid funding cuts.
Source: National Law Review · jdsupra.com
The Lancet series validates the E-MOTIVE bundle as a low-cost, scalable fix for postpartum hemorrhage, which accounts for up to 38% of maternal deaths in India. For healthcare providers, the drape-based early detection and standardized treatment protocol promise to overhaul emergency obstetric workflows and save thousands of lives.
Source: Kirti Pandey (in) · Kirti Pandey (in)
India handed over 6 ambulances and signed an affordable generic medicines agreement with Seychelles under the Janaushadhi Scheme during PM Modi's visit, strengthening the island nation's public health system.
The Flaus electric flosser is gaining popularity for making daily flossing faster and more effective, potentially improving patient compliance and oral health outcomes. Its recyclable head program also appeals to eco-conscious consumers, positioning it as a tool that merges preventive care with sustainability.
Source: Griffin Wynne (in) · Griffin Wynne (in)
Solius Labs launches the first OTC FDA-cleared personalized UVB light therapy device, claiming significant health benefits with minimal UV risk. For health consumers, it could offer a convenient way to boost vitamin D and improve mood without sun exposure.
A Kansas doctor reports that 1 in 60 patients at her clinic have a false positive Clearblue test, leading to wasted travel and emotional strain for women traveling from abortion-restrictive states.
Source: Alanna Vagianos (in) · Alanna Vagianos (us)
Outset Medical's quarterly earnings miss by $0.04 EPS highlights challenges in the medical devices sector, potentially affecting dialysis technology adoption. This development underscores operational hurdles amid growing demand for home-based care solutions. Investors and healthcare providers should monitor how this influences future R&D and market strategies in health IT.
Source: tickerreport.com · dailypolitical.com
Clarity Pharmaceuticals has entered into a multi-year manufacturing supply agreement with Theragenics for the production of copper-64 (Cu-64). This partnership secures a reliable, large-scale supply of the isotope to support Clarity's clinical trials and future commercialization of its Targeted Copper Theranostics platform.
ZenoWell and USound GmbH have announced a strategic cooperation to develop advanced sensing technologies for next-generation wearable devices. The partnership leverages USound’s MEMS expertise to enhance the precision and form factor of health-monitoring hardware.
Source: finanznachrichten.de · manilatimes.net
Researchers have developed an ultra-miniature neural implant smaller than a grain of salt capable of wireless brain activity monitoring for over a year. Powered by laser light and infrared signaling, the device eliminates invasive wiring and represents a major leap in long-term neurotechnology.
Source: sciencedaily.com · sciencedaily.com
MaxCyte reported a 15% revenue decline for 2025, driven by the loss of six clinical programs and reduced spending from its largest customer. Despite these headwinds, the company expanded its installed base to 857 units and significantly improved gross margins through aggressive cost-cutting measures.
Source: Motley Fool Transcribing (us) · Motley Fool Transcribing (us)
Pomerantz LLP has initiated a class action investigation and filing against Boston Scientific Corporation (BSX), alleging the medical device giant made misleading statements regarding its clinical trials and business prospects. The litigation follows a period of heightened volatility for the company's cardiovascular portfolio, specifically concerning the FARAPULSE PFA system and recent trial adjustments.
As global diabetes prevalence reaches record highs, the shift toward localized medical device production is driving a surge in glucometer manufacturing plant investments for 2026. This briefing analyzes the cost structures, regulatory hurdles, and technological requirements for establishing high-volume diagnostic production facilities.
Source: openpr.com · openpr.com
Invenomic Capital Management has fully liquidated its $24.29 million position in Haemonetics Corporation, a leader in blood and plasma management technology. The exit comes as the stock underperformed the broader market by 25% over the past year, signaling a shift in institutional sentiment toward the medical device sector.
Source: Jonathan Ponciano (us) · fool.com
Researchers have successfully engineered the first lab-grown oesophagus, providing a transformative solution for children born with Oesophageal Atresia. This tissue-engineered breakthrough uses a patient's own cells to create a functional organ, potentially eliminating the need for high-risk invasive surgeries.
Source: oxfordmail.co.uk · london-now.co.uk
AeroDel has entered into an exclusive licensing agreement with Zydus Lifesciences to launch the Aerolife Mini, a pioneering 'Always Attached' pMDI enhancer. The device is designed to improve medication delivery for respiratory patients by offering a portable, foldable solution that remains permanently fixed to the inhaler.
Source: nepalnational.com · news.webindia123.com
Both Nyxoah and Alumis reported quarterly earnings that missed analyst expectations by $0.04 per share, reflecting the high operational costs of late-stage clinical trials and pre-commercialization activities. Despite the financial shortfall, both companies remain on track with pivotal regulatory and clinical milestones in the sleep apnea and immunology sectors.
Source: tickerreport.com · dailypolitical.com
Heartflow (NASDAQ: HTFL) reported a significant 40.5% year-over-year revenue increase in its latest quarterly results, though earnings per share fell short of analyst expectations. The company posted a loss of $0.29 per share, missing the consensus estimate of $0.16 as it continues to invest heavily in market expansion.
Source: Zolmax · Daily Political
Sera Prognostics reported a narrowed annual net loss of $31.9 million for 2025, supported by a robust $95.8 million cash position that extends its operational runway into 2028. Following the successful publication of its PRIME study—which demonstrated a 56% reduction in very preterm births—the company is aggressively shifting its focus toward state-level payer engagement and commercial scaling.
ClearPoint Neuro reported a 17.8% year-over-year revenue increase for 2025, reaching $37 million, bolstered by the acquisition of Eris Holdings and growth in its biologics segment. Despite rising operational expenses and integration costs, the company demonstrated strong momentum in its neurosurgery navigation and drug delivery platforms.
Source: Motley Fool Transcribing (us) · fool.com
Kestra Medical (KMTS) delivered a robust Q3 2026 with $24.6 million in revenue, driven by a 58% surge in Assure system prescriptions. Despite a widening net loss of $34.2 million, the company secured critical access to the VA Federal Supply Schedule and expanded its Florida Medicaid footprint.
Source: fool.com · Motley Fool Transcribing (us)
Regentis Biomaterials has patented a breakthrough solvent-free manufacturing process for its GelrinC hydrogel, achieving a 400% increase in production yield. This advancement positions the company for large-scale commercialization while improving the environmental profile and cost-efficiency of its cartilage repair solution.
Source: finanznachrichten.de · tennesseedaily.com
BioNxt Solutions has finalized a strategic agreement for the commercialization of its Cladribine Oral Dissolvable Film (ODF) in Eurasia. The deal follows critical patent grants in both Europe and Eurasia, marking a transition from development to market entry for the company's Multiple Sclerosis treatment platform.
Source: finanznachrichten.de · irishsun.com
Alcon has officially terminated its merger agreement with LENSAR, a leader in femtosecond laser technology, citing insurmountable opposition from the Federal Trade Commission (FTC). The collapse of the deal highlights increasing regulatory scrutiny over consolidation within the specialized medical device and ophthalmic surgery sectors.
Stryker Corporation has confirmed significant disruptions to its global manufacturing and order fulfillment systems following a sophisticated cyberattack attributed to the Iranian-linked group Handala. The incident, characterized as a 'wiper' attack, has forced the medical technology leader to take key systems offline, impacting the supply of critical surgical and orthopedic equipment.
CPAP.com has launched a promotional campaign for its At Home Sleep Test featuring the Wesper device to coincide with Sleep Awareness Month. The clinical-grade kit aims to address the global underdiagnosis of sleep apnea by providing lab-quality insights and physician-led prescriptions from a home setting.
Source: Julia Ornedo (us) · Tamilore Oshikanlu (us)
Pro-Iranian hacking group Handala has claimed responsibility for a major cyberattack on U.S. medical technology giant Stryker, allegedly destroying 50 terabytes of data. The incident marks a shift toward ideologically motivated data destruction targeting critical healthcare infrastructure amid escalating geopolitical conflict.
India's medical device sector is facing a critical supply chain disruption as the Iran war drives a 35% surge in polypropylene prices and domestic gas rationing limits production. Small and medium enterprises, which comprise 90% of the industry, are struggling to maintain output of essential consumables like syringes and IV bags.
Sky Labs has announced its formal support for the American Heart Association’s Established Investigator Award for Clinical Hypertension. The partnership aims to bridge the gap between wearable health technology and rigorous clinical research in blood pressure management.
Source: manilatimes.net · finanznachrichten.de
Q4 2025 earnings reports from specialized technology leaders, including Shoulder Innovations and Blend Labs, highlight a significant shift toward AI-driven automation and rapid commercial scaling in healthcare and related sectors.
Stryker Corp. has suffered a massive global network disruption following a retaliatory cyberattack by the Iran-linked group Handala. The destructive 'wiper' attack allegedly disabled 200,000 devices and exfiltrated 50TB of data, marking a major escalation in geopolitical cyber warfare.
Source: Tony Jackson (au) · Cb_usr (jm)
Lords Mark Industries has entered a strategic partnership with the Center for Materials for Electronics Technology (C-MET) to develop a pioneering AI-based breast cancer detection device. This collaboration aims to leverage advanced materials and artificial intelligence to create a non-invasive, highly accurate screening tool for early-stage diagnosis.
Source: aninews.in · news.webindia123.com
Nelipak has inaugurated its Asia-Pacific Technical Development Center (TDC), a strategic facility designed to provide localized design, prototyping, and testing for medical packaging. This expansion aims to accelerate time-to-market for regional medical device manufacturers by offering direct access to specialized engineering expertise.
BabyCue Pvt. Ltd. has received strategic backing from India's Technology Development Board (TDB) and the Department of Science and Technology (DST) to advance its rapid diagnostic platform. The initiative aims to address the critical need for fast, accurate diagnosis of childhood diarrhea, a leading cause of mortality in developing regions.
Source: biospectrumindia.com · biospectrumindia.com
GOOD Vision has unveiled its 'oka³y ! ™' freeform orthokeratology system, a product of research from The Hong Kong Polytechnic University, at a global debut in Geneva. The technology aims to redefine precision in myopia control through advanced freeform lens design, transitioning from academic research to a commercial medical device.
Source: itnewsonline.com · businessdayghana.com
The 2026 Bioelectronic Medicine Forum in New York City will feature a keynote from the founder of Iota Biosciences, a leader in miniaturized neural implants. The event highlights a growing international ecosystem of neurotech startups, including Coherence Neuro and Spiro Medical, focused on 'electroceuticals.'
Source: Rutland Herald · Times Argus
CooperCompanies (NASDAQ: COO) reported fourth-quarter 2025 financial results that met analyst expectations, driven by consistent performance across its CooperVision and CooperSurgical business units. The results underscore the company's resilience in the medical device sector despite broader macroeconomic fluctuations.
Source: markets.financialcontent.com · markets.financialcontent.com
The founder of Iota Biosciences has been named the keynote speaker for the 2026 Bioelectronic Medicine Forum in New York City. This announcement highlights the growing prominence of 'neural dust' technology and its potential to revolutionize chronic disease management through ultra-miniature bioelectronic implants.
Source: itnewsonline.com · winknews.com
908 Devices and Strata Critical Medical reported Q4 2025 results highlighting a strategic pivot toward high-margin consumables and expanded clinical utility. As both firms navigate the post-pandemic capital equipment landscape, their focus on point-of-need diagnostics and regenerative therapies is driving a transition toward more predictable, recurring revenue streams.
Source: insidermonkey.com · insidermonkey.com
STAAR Surgical reported a narrowed net loss for the fourth quarter, signaling a potential turnaround for the implantable lens manufacturer. The results come as the medical device sector navigates a complex global landscape, marked by industrial output volatility in key Asian markets like South Korea.
Quanterix reported a 25% year-over-year revenue increase to $43.9 million in Q4 2025, driven by a surge in diagnostics partner revenue and critical regulatory milestones. The company achieved a commercial breakthrough with a $897 CMS reimbursement rate for its Lucent AD Complete test, positioning it for large-scale clinical adoption.
Smith & Nephew has introduced ambitious financial targets for FY26 and FY28, signaling a definitive shift from its operational recovery phase to a sustained growth trajectory. The company’s Q4 results underscore the resilience of its Orthopaedics and Sports Medicine segments, supported by the continued rollout of the CORI robotics platform.
Source: Seeking Alpha · Seeking Alpha
Wearable startup CUDIS has unveiled its latest smart ring, featuring an integrated AI-fueled health coach and a gamified reward system. The device incentivizes wellness by allowing users to earn points for healthy behaviors, which can be redeemed for various health products.
Source: TechCrunch · businessghana.com
According to our own tracking database, this category has accumulated 73 medical devices stories since coverage began. This page aggregates the latest medical devices stories within our healthcare coverage area. Every story is cross-referenced across multiple primary sources, scored for sentiment and operational impact, and timestamped so fresh developments surface first. We track devices, diagnostics, wearables and surface the angles a domain expert would actually read.
Story selection follows our editorial methodology — impact scoring weights regulatory, financial, and operational developments distinctly. Sentiment is classified across five tiers via supervised classification trained on labeled industry corpora. See our glossary for term definitions and our trends index for longitudinal patterns across the healthcare beat.
Stories only surface on this page once the classifier scores them at a minimum 35 percent relevance to the category. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
| Signal | What it tells you |
|---|---|
| Verified by N sources | Confidence the story isn't a single-source rumor — N≥2 means the development is independently corroborated. |
| Impact score (1-10) | Estimated regulatory, financial, or operational impact. 8+ indicates a story experienced operators should act on. |
| Sentiment | Five-tier classification (very bullish through very bearish) trained on labeled healthcare-specific corpora. |
| Time stamp | Recency. Fresh stories (under 1h) render with a highlighted timestamp; stale stories (≥24h) render dimmed. |